Pharma AI|29 Mar 2026
Smartcat is leveraging AI and a compliance focus to meet the surging demands for enterprise content.
The Story
The company highlights its adherence to regulatory standards while deploying AI solutions.
Why It Matters
Content generation and multilingual translation are massive cost centers for European pharma, CROs, and biotech. This signals that AI tools are finally maturing beyond hype, directly addressing critical compliance and data sovereignty needs for regulated content workflows, not just speed.
What To Do About It
I can help you pilot AI for regulatory content generation or translation, ensuring GDPR and EU AI Act compliance from day one, often leveraging your existing M365 investment.
regulatory affairs AI pharmabiotech startup AI compliancesmall pharma AIpharma GDPR AIpharma SME AI
